CClinicalTrials.gg
Status unknownNCT03535012Updated May 25, 2018

Sensory Recovery of Reconstructed Breast With Breast Reconstructive Options

An observational study in Breast Cancer, sponsored by Yonsei University. Status unknown at 1 site in Korea, Republic of. Open to female participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2018-05-25.

Sponsored by Yonsei University · Observational

The sponsor has not verified this record recently (last verified May 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
20 Years and older
Sex
Female
01

Study summary

Over the past 10 years, there have been substantial improvements in breast reconstruction by plastic surgeons, and much has been achieved in aesthetic restoration after mastectomy. Advances in both microsurgery and implants have allowed for a wider variety of surgical methods, and procedural skills that minimize donor site complications have been developed.

With such satisfactory aesthetic results, interest has recently increased not only in breast reconstruction but also in sensory recovery. Due to the growing expectation of patients, sensory discomfort may decrease overall patient satisfaction with breast reconstruction despite good aesthetic results. Hence, for qualitative improvement of breast reconstruction surgery, efforts must be made to restore sensation in the reconstructed breast. There has been little research on the mechanism of sensory recovery despite its clinical importance. This study aimed to compare the degree of sensory recovery in the reconstructed breast using various reconstruction methods as well as to evaluate the status of neural regeneration with harvesting the tissues when nipple reconstruction is performed.

02

Conditions studied

  • Breast Cancer
03

In context

Lead sponsor

Yonsei University is the lead sponsor of 1,387 studies on the registry; 231 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

This study will be conducted by dividing the subjects into two groups(25 per each arm) according to the method of reconstruction: implant vs. abdominal tissue. It is difficult to determine a sample size that can establish statistical significance based on previous studies. Therefore, the number of targeted subjects was estimated based on the number of patients that can generally be recruited during the study period.

Inclusion criteria

  • Female adults over 20 years of age
  • Patients who have undergone or plan to undergo total mastectomy and immediate breast reconstruction after the diagnosis of breast cancer (including carcinoma in situ)
  • written consent to study participation

Exclusion criteria

Exclusion Criteria:

  • presence of neuropathy that may hinder accurate assessment of sensation
  • presence of dermatological condition that may hinder accurate assessment of sensation
  • inability to provide written consent
  • decided by the research team to be unsuitable for this study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Reconstruction using an implant

    Immediate 2 stage implant based breast reconstruction after mastectomy. All expanders are placed in the subpectoralis muscle using ADM as a sling. After expansion of the tissue expander change to the permanent implant is performed.

  • Reconstruction using abdominal tissue

    immediate free DIEP flap breast reconstruction after mastectomy. DIEP(deep inferior epigastric perforator) free flap was prepared and transferred to the breast pocket. Microanastomosis was done under the microscopic magnification. On sitting position, free flap was inset into breast pocket with confirming of satisfactory inflammatory fold.

06

What researchers measure

Primary outcomes

  1. Sensory recovery in the reconstructed breast according to reconstructive options

    Subjects will be followed up with quantitative sensory testing at 3 months (±1 month) after immediate breast reconstruction surgery.

    Time frame: 3 months (±1 month) after immediate breast reconstruction surgery

  2. Sensory recovery in the reconstructed breast according to reconstructive options

    Subjects will be followed up with quantitative sensory testing at 6 months (±1 month) after immediate breast reconstruction surgery.

    Time frame: 6 months (±1 month) after immediate breast reconstruction surgery

  3. Sensory recovery in the reconstructed breast according to reconstructive options

    Subjects will be followed up with quantitative sensory testing at 12 months (±2 months) after immediate breast reconstruction surgery.

    Time frame: 12 months (±2 months) after immediate breast reconstruction surgery

  4. Sensory recovery in the reconstructed breast according to reconstructive options

    Subjects will be followed up with quantitative sensory testing at 18 months (±2 months) after immediate breast reconstruction surgery.

    Time frame: 18 months (±2 months) after immediate breast reconstruction surgery

07

Study locations

1 of 1 sites recruiting
  • Department of Plastic Surgery, Yonsei University School of Medicine, Severance Hospital
    Seoul, 03722, Korea, Republic of
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 25, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03535012
Lead sponsor
Yonsei University
Responsible party
Sponsor
First posted
May 24, 2018
Start date
Sep 1, 2016
Primary completion
Feb 28, 2020 (estimated)
Completion
Feb 28, 2020 (estimated)
Last update
May 25, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion